Resources

Uterine Fibroids: Assessing Unmet Needs From Bench to Bedside

Aninye, I. & Laitner, M.

Summarizes research gaps, clinical needs, and policy recommendations for improving diagnosis, treatment, and care of uterine fibroids to guide future efforts.

Vaginal dysbiosis and the potential of vaginal microbiome-directed therapeutics

Valeriano et al.

Reviews vaginal dysbiosis, microbiome-directed therapeutics, and summarizes clinical trial data and regulatory challenges for developing vaginal live biotherapeutic products.

Vaginal microbiota transplantation is a truly opulent and promising edge: fully grasp its potential

Meng et al.

Summarizes current knowledge and research on vaginal microbiota transplantation for treating vaginal, uterine, and gynecological disorders, highlighting therapeutic potential and research needs.

Vitamin and Mineral Requirements in Human Nutrition

World Health Organization

Summarizes recommended nutrient intakes, food sources, bioavailability, and strategies to improve micronutrient adequacy for guiding nutrition policy and programs.

What Makes Clinical Research in Developing Countries Ethical? The Benchmarks of Ethical Research

Emanuel, E. J. et al.

Provides information on practical ethical benchmarks for assessing and guiding clinical research in developing countries, aiming to ensure unified, consistent ethical standards.

WHealth Index

Kearney

Provides information on global wealth trends, investor sentiment, and financial behaviors to help understand and anticipate shifts in the wealth management industry.

Where Does The Money Go To? Cost Analysis of Gynecological Patients With a Benign Condition

Pynnä, K. et al.

Provides information on direct and indirect costs of treating benign gynecological conditions to guide resource allocation and improve care processes.

WHO Antenatal Care Recommendations for a Positive Pregnancy Experience: Nutritional Interventions Update: Multiple Micronutrient Supplements During Pregnancy

World Health Organization

Provides updated WHO recommendations, evidence, and research priorities on antenatal multiple micronutrient supplements for policy-makers and health professionals.

Who Do We Invent For? Patents by women focus more on women’s health, but few women get to invent

Koning, R. et al.

Summarizes how patents by women are more likely to focus on women’s health, highlighting the impact of inventor gender on innovation focus and representation.

WHO Global Benchmarking Tool (GBT) for Evaluation of National Regulatory System of Medical Products

World Health Organization

Summarizes benchmarks, indicators, and guidance for evaluating and strengthening national medical product regulatory authorities for improved regulatory system performance.

WHO’s adoption of SAGER guidelines and GATHER: setting standards for better science with sex and gender in mind

Heidari et al.

Summarizes WHO's adoption of SAGER and GATHER guidelines to improve sex and gender data reporting for advancing health equity and evidence-based policy.

Women are Credited Less in Science than Men

Ross, M. B. et al.

Provides information on gender disparities in scientific credit attribution, using administrative, survey, and qualitative data to document women’s under-recognition in research teams.

Women’s Careers in Biomedical Sciences: Implications for the Economy, Scientific Discovery, and Women’s Health

Plank-Bazinet, J. L. et al.

Reviews data on women's underrepresentation in academic medicine, arguing increased participation benefits the economy, scientific discovery, and women's health.

Women’s Health R&D Funding Guide

University of Washington Strategic, Analysis, Research & Training (START) Center

Provides a curated snapshot of the global funding landscape for women’s health research and development, focusing on grants, venture capital (VC), industry partnerships, and technical support .

Women’s Health Research Lacks Funding – In A Series Of Charts

Smith, K. 

Provides information on the underfunding of female-dominant diseases relative to their burden and models benefits of increased women's health research funding.

Women’s Participation in Cardiovascular Clinical Trials From 2010 to 2017

Jin, X. et al.

Reviews data on women’s participation in cardiovascular clinical trials (2010–2017) by disease, intervention, sponsor, and region to assess equity in representation.

Women’s Health Action Plan 2024-2025 Phase 2: An Evolution in Women’s Health

Ireland DOH

Summarizes key actions, achievements, and planned investments in Ireland’s women’s health services for 2024-2025 to guide policy and service development.

Women’s health economics: investing in the 51 per cent

NHS Confederation

Provides information on the economic impact of women’s health conditions, return on investment in services, and inequalities, to inform policy and funding decisions.